MET — Metlife Share Price

As of Today at 22:01 UTC, shares in Metlife are trading at $80.65. This share price information is delayed by 15 minutes.

Shares in Metlife last closed at $80.65 and the price had moved by +14.95% over the past 365 days. In terms of relative price strength the Metlife share price has outperformed the S&P500 Index by +2.76% over the past year.

The overall consensus recommendation for Metlife is Buy. You can view the full broker recommendation list by unlocking its StockReport.

The Metlife dividend yield is 2.7% based on the trailing twelve month period.

Last year, Metlife paid a total dividend of $2.18, and it currently has a trailing dividend yield of 2.7%. We do not have any data on when Metlife is to next pay dividends.

We do not have data on when Metlife is to next pay dividends.  The historic dividend yield on Metlife shares is currently 2.7%.

To buy shares in Metlife you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

As of the previous close price of $80.65, shares in Metlife had a market capitalisation of $54.14bn.

Here are the trading details for Metlife: 

• Country of listing: United States
• Exchange: NYQ
• Ticker Symbol: MET

Based on an overall assessment of its quality, value and momentum Metlife is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

The analyst consensus target price for shares in Metlife is $94.92.  That is 17.69% above the last closing price of $80.65.

Analysts covering Metlife currently have a consensus Earnings Per Share (EPS) forecast of $9.04 for the next financial year.

An important predictor of whether a stock price will go up is its track record of momentum.  Price trends tend to persist, so it's worth looking at them when it comes to a share like Metlife. Over the past six months, its share price has underperformed the S&P500 Index by -5.87%.

As of the last closing price of $80.65, shares in Metlife were trading -0.6% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

The Metlife PE ratio based on its reported earnings over the past 12 months is 8.34. The shares last closed at $80.65. 

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Metlife's management team is headed by: 

• Robert Hubbard - NEC
• Michel Khalaf - PRE
• John McCallion - CFO
• Kishore Ponnavolu - CEX
• Susan Podlogar - CHO
• Steven Goulart - EVP
• Esther Lee - EVP
• Michael Roberts - EVP
• Marlene Debel - EVP
• Stephen Gauster - EVP
• Bill Pappas - EVP
• Ramy Tadros - EVP
• Robin Gordon - OTH
• Cindy Pace - OTH
• Cheryl Grise - IND
• Carlos Gutierrez - IND
• Gerald Hassell - IND
• David Herzog - IND
• Edward Kelly - IND
• William Kennard - IND
• Catherine Kinney - IND
• Diana McKenzie - IND
• Denise Morrison - IND
• Mark Weinberger - IND